Explore
Communities in English
Advertise on Engormix

The use of monovalent or bivalent IBV vaccines significantly reduces clinical signs but not viral load after heterologous challenge

Published: January 7, 2021
Summary
...
Related topics
Authors:
Dr. Brian Jordan
University of Georgia
Deborah Hilt
University of Georgia
Dr. Mark Jackwood
University of Georgia
Recommend
Comment
Share
MADHUSUDHAN.K.N
3 de marzo de 2020
Thanks for updating us
Recommend
Reply
1
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Join Engormix and be part of the largest agribusiness social network in the world.